Use of a Cysteine-rich Whey Protein Isolate in Post COVID-19 Cognitive Impairment

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

January 1, 2025

Conditions
COVID-19 (SARS-CoV-2 Infection)
Interventions
OTHER

Intervention with Consolidated Cysteine (Immunocal) 20 g per day

CRWPI Immunocal® (Immunotec™) was administered at a dose of 20 grams (2 sachets once daily) for 12 consecutive weeks. The research team delivered Immunocal directly to the subjects and instructed them on how to mix and self-administer it.

BEHAVIORAL

Cognitive rehabilitation workshops

Neuropsychological rehabilitation consisted of in-person group sessions for 40 adults (18 years or older) to work on cognitive functions such as memory and attention. Each session lasted 45 minutes. These sessions were held three times a week for a period of 12 weeks.

Trial Locations (1)

760001

Doctor's office, Santiago de Cali

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Immunotec Inc.

INDUSTRY

lead

Universidad Libre seccional Cali

OTHER

NCT07184398 - Use of a Cysteine-rich Whey Protein Isolate in Post COVID-19 Cognitive Impairment | Biotech Hunter | Biotech Hunter